DrugPatentWatch Database Preview
Drugs in Development Information for Eniluracil
What is the development status for investigational drug Eniluracil?
Eniluracil is an investigational drug.
There have been 8 clinical trials for Eniluracil.
The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 1999.
The most common disease conditions in clinical trials are Colorectal Neoplasms, Colonic Neoplasms, and Carcinoma. The leading clinical trial sponsors are National Cancer Institute (NCI), Adherex Technologies, Inc., and Investigator initiated study.
Summary for Eniluracil
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 4,432 |
| WIPO Patent Applications | 1,906 |
| Japanese Patent Applications | 4 |
| Clinical Trial Progress | Phase 3 (1999-04-01) |
| Vendors | 45 |
Recent Clinical Trials for Eniluracil
| Title | Sponsor | Phase |
|---|---|---|
| Study of Eniluracil + 5-Fluorouracil (5-FU) + Leucovorin Versus Capecitabine in Metastatic Breast Cancer | Adherex Technologies, Inc. | Phase 2 |
| Eniluracil Hand Foot Syndrome | Investigator initiated study | Phase 1 |
| Eniluracil Hand Foot Syndrome | West Virginia University | Phase 1 |
Clinical Trial Summary for Eniluracil
Top disease conditions for Eniluracil
Top clinical trial sponsors for Eniluracil
US Patents for Eniluracil
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
